ZA702530B - Improvements relating to pharmaceutical compositions comprising beta-adrenolytics - Google Patents
Improvements relating to pharmaceutical compositions comprising beta-adrenolyticsInfo
- Publication number
- ZA702530B ZA702530B ZA702530A ZA702530A ZA702530B ZA 702530 B ZA702530 B ZA 702530B ZA 702530 A ZA702530 A ZA 702530A ZA 702530 A ZA702530 A ZA 702530A ZA 702530 B ZA702530 B ZA 702530B
- Authority
- ZA
- South Africa
- Prior art keywords
- adrenolytics
- beta
- pharmaceutical compositions
- improvements relating
- relating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19691919342 DE1919342A1 (de) | 1969-04-16 | 1969-04-16 | Herzwirksame Kombinationspraeparate |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA702530B true ZA702530B (en) | 1971-01-27 |
Family
ID=5731393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA702530A ZA702530B (en) | 1969-04-16 | 1970-04-15 | Improvements relating to pharmaceutical compositions comprising beta-adrenolytics |
Country Status (8)
Country | Link |
---|---|
BE (1) | BE748820A (de) |
CA (1) | CA940048A (de) |
DE (1) | DE1919342A1 (de) |
FR (1) | FR2042334B1 (de) |
GB (1) | GB1305644A (de) |
IE (1) | IE34187B1 (de) |
NL (1) | NL7005435A (de) |
ZA (1) | ZA702530B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4000282A (en) | 1974-12-16 | 1976-12-28 | Merck & Co., Inc. | 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines |
LU76150A1 (de) * | 1976-11-08 | 1978-07-10 | ||
FR2401661A1 (fr) * | 1977-08-29 | 1979-03-30 | Italiana Med Sint | Compositions pharmaceutiques a base de medicaments anxiolytiques et d'inhibiteurs du systeme b-adrenergique |
US4279913A (en) * | 1978-01-04 | 1981-07-21 | Merck & Co., Inc. | Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines |
US4294969A (en) * | 1979-01-29 | 1981-10-13 | Merck & Co., Inc. | Process for producing 2-bromo-3,5-disubstituted pyridines |
DE2926653A1 (de) * | 1979-07-02 | 1981-01-22 | Sandoz Ag | Neue therapeutische verwendung von organischen verbindungen |
US4416735A (en) | 1982-06-17 | 1983-11-22 | Eastman Kodak Company | Diluent and method for potentiometric assay of liquids |
US4468391A (en) * | 1982-06-25 | 1984-08-28 | Ayerst, Mckenna & Harrison, Inc. | Combination of β-adrenoceptor antagonists and anxiolytic agents |
-
1969
- 1969-04-16 DE DE19691919342 patent/DE1919342A1/de active Pending
-
1970
- 1970-04-07 IE IE439/70A patent/IE34187B1/xx unknown
- 1970-04-08 CA CA079,531A patent/CA940048A/en not_active Expired
- 1970-04-10 BE BE748820D patent/BE748820A/xx unknown
- 1970-04-15 ZA ZA702530A patent/ZA702530B/xx unknown
- 1970-04-15 NL NL7005435A patent/NL7005435A/xx unknown
- 1970-04-16 GB GB1824370A patent/GB1305644A/en not_active Expired
- 1970-04-16 FR FR7013780A patent/FR2042334B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2042334A1 (de) | 1971-02-12 |
IE34187L (en) | 1970-10-16 |
IE34187B1 (en) | 1975-03-05 |
BE748820A (fr) | 1970-10-12 |
NL7005435A (de) | 1970-10-20 |
DE1919342A1 (de) | 1970-12-03 |
GB1305644A (de) | 1973-02-07 |
FR2042334B1 (de) | 1974-08-30 |
CA940048A (en) | 1974-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU458705B2 (en) | Improvements in or relating to pharmaceutical compositions | |
ZA713539B (en) | Pharmaceutical compositions | |
ZA705411B (en) | Improvement relating to beta-aryl-2-aminoalkoxy-styrenes | |
ZA717083B (en) | New pharmaceutical compositions | |
HK13377A (en) | Pharmaceutical compositions | |
ZA702530B (en) | Improvements relating to pharmaceutical compositions comprising beta-adrenolytics | |
CA930306A (en) | Pharmaceutical compositions | |
MY7400119A (en) | Pharmaceutical compositions comprising lincomycin derivatives | |
CY845A (en) | Antiineectious pharmaceutical compositions | |
IE36108B1 (en) | Pharmaceutical compositions | |
ZA715832B (en) | Pharmaceutical compositions | |
CA930305A (en) | Pharmaceutical compositions | |
ZA704998B (en) | Pharmaceutical compositions | |
ZA708508B (en) | Therapeutic compositions | |
ZA695903B (en) | Pharmaceutical compositions | |
ZA716461B (en) | Pharmaceutical compositions | |
AU1347370A (en) | Improvements in or relating to therapeutic compositions | |
IL33808A0 (en) | Pharmaceutical composition comprising phenylbutazon | |
IE34882L (en) | Pharmaceutical composition | |
ZA704677B (en) | Therapeutic compositions | |
ZA704678B (en) | Therapeutic compositions | |
AU442181B2 (en) | Pharmaceutical compositions | |
AU445199B2 (en) | Antiinfectious pharmaceutical compositions | |
CA807196A (en) | Pharmaceutical compositions | |
AU439713B2 (en) | Pharmaceutical compositions |